Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
victoria.woodcock@oncology.ox.ac.uk

Research groups

Multi-dimensional Innate and Adaptive lmmune responses

Victoria Woodcock

Clinical Research Fellow

Recent publications

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.
Journal article

Woodcock VK. et al, (2018), Br J Cancer, 118, 770 - 776
Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Conference paper

Ghazaly E. et al, (2017), ANNALS OF ONCOLOGY, 28
Simultaneous bilateral spontaneous hydropneumothorax: a rare presentation of bilateral malignant pleural mesothelioma.
Journal article

Fayed HE. et al, (2013), BMJ Case Rep, 2013

More publications